-
Document de presse | 2013.02.06
Treatment of Cutaneous Leishmaniasis: Study of Phase III Shows Antibiotic Cream Has High Cure Rate, Few Side Effects
An international research partnership from Tunisia, France and the United States has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an antibiotic cream. CL is a parasitic disease that causes disfiguring lesions and affects 1.5 million people worldwide annually, including the socio-economically disadvantaged in the...
-
Document de presse | 2011.08.02
The troubling emergence of multi-drug resistant Salmonella
As part of a vast international study, researchers from the Institut Pasteur, the INRA and the French Institute for Public Health Surveillance have tracked the sudden and worrying emergence of a Salmonella strain that has developed resistance to almost every possible antibiotic treatment. The study has retraced the evolution of the bacteria throughout the last 50 years. It has notably determined...
-
Document de presse | 2008.10.05
Nobel Prize in Medicine 2008 awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier
The Nobel Prize in Medicine 2008 has been awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier for their discovery of the human immunodeficiency (AIDS) virus in 1983 at the Institut Pasteur, and to Prof. Harald zur Hausen for his discovery of the human papillomavirus, which is responsible for cervical cancer. Press releaseParis, october 6, 2008 “Twenty five...
-
Document de presse | 2007.06.28
Chikungunya: virus target cells identified
Researchers from the Institut Pasteur and CNRS have identified for the first time the target cells of the Chikungunya virus disease (the "stooped man's disease"), which is currently breaking out in India and Gabon. Their results, obtained in collaboration with clinicians from the island of Reunion, were published in PLoS Pathogens and in PLoS ONE. Press release Paris,...
-
Document de presse | 2007.06.21
Rabies in the bat
The largest active surveillance study of rabies in bats ever performed was carried out by researchers from the Institut Pasteur and from the University of Barcelona in Spain. This study, published in 'PLoS ONE', enabled the evaluation of the dynamics of the infection in its animal reservoirs and had useful implications for public health. The study also confirmed a limited but still real...
-
Document de presse | 2005.05.12
The Origins of Leprosy Using Genomics to Outline the History of an Age-Old Disease
Researchers at Institut Pasteur recently published the results of a study in the journal Science tracing the dissemination of leprosy throughout the world over the centuries. Because the bacillus responsible for the disease, Mycobacterium leprae cannot, for various reasons, be cultivated in the laboratory, this research team has used comparative genomics techniques to prove that a single clone of...
-
Document de presse | 2005.04.24
Dengue: we are not all equal in the eyes of this disease
Dengue, a virosis which is raging in tropical areas, is transmitted by mosquitoes. It affects 100 million people each year throughout the world. The genetic analysis of a large cohort of subjects who were hospitalised with this disease in Thailand has enabled researchers at the Institut Pasteur, together with researchers from Inserm (the National Institute for Health and Medical Research), to...
-
Document de presse | 2004.10.10
Inauguration of the Institut Pasteur of Shanghai - Chinese Academy of Sciences
The Institut Pasteur of Shanghai-Chinese Academy of Sciences is being inaugurated today in the presence of Mr. Jacques Chirac, President of the French Republic, Mr. Lu Yongxiang, President of the Chinese Academy of Sciences, Mr. Han Zheng, Mayor of Shanghai, Mr. Philippe Kourilsky, President of the Institut Pasteur, and the Year of France in China's Committee of Honour. Press...
-
Document de presse | 2004.03.17
World Tuberculosis Day (March 24): The Institut Pasteur engaged in the fight
With a third of the world's population infected, 2 million deaths and 8.5 million new cases each year, tuberculosis (TB) is the number two infectious disease in the world after AIDS, without sparing France, where 6300 new cases occurred last year. The prevalence of the resistance to antibiotics and the emergence of multiresistance are worrying at the international level, and is a risk for...
-
Document de presse | 2013.11.27
Clinical trial launched to treat Sanfilippo B syndrome using gene therapy
A phase I/II gene therapy clinical trial for children suffering from Sanfilippo B syndrome, a rare genetic disease, enrolled a first patient in October of this year. The trial is being carried out and coordinated by the Institut Pasteur (the trial’s sponsor), Inserm, AFM-Téléthon and Vaincre les Maladies Lysosomales (VML). It is being conducted at Bicêtre Hospital (AP-HP) in Paris. If the...